The expanded FDA clearance for Collaboration Live (Philips) gives clinicians the option to consult on or diagnose ultrasound images from their mobile devices.
In a promising development for real-time remote collaboration between physicians consulting on ultrasound images, the Food and Drug Administration (FDA) has expanded the 510(k) clearance of Collaboration Live (Philips) to include use of the tele-ultrasound platform on additional mobile devices.
Philips said the expanded FDA clearance will significantly enhance efficiency and flexibility for clinicians as they will no longer be restricted to a personal computer (PC) when consulting with colleagues via Collaboration Live. The secure platform reportedly allows clinicians who are using Collaboration Live on the Philips EPIQ or Affiniti ultrasound systems to share the screen and video stream directly to compatible PCs and mobile devices of fellow clinicians, according to the company.
“Sonographers no longer have to feel they are alone or limited to only acquiring ultrasound images and preparing a report for subsequent clinical review,” noted Gerois Di Marco, the general manager of global ultrasound services and solutions at Philips. “They can now call on the expertise of colleagues during ultrasound examinations to deliver on the spot accurate diagnosis that every patient deserves.”
Another benefit of the tele-ultrasound platform is the ability of the ultrasound user to cede control to the remote clinician, enabling him or her to make measurements, obtain a new image or enhance image quality, according to Philips.
Michael S. Ruma, MD, MPH, who is affiliated with Perinatal Associates of New Mexico, said the technology of Collaboration Live can have an impact in extending quality care to underserved communities.
“We have been able to open a strictly telemedicine office to serve our patients in rural communities because Collaboration Live enables us to carry out a full diagnostic visit remotely,” explained Dr. Ruma, a fellow of the American College of Obstetricians and Gynecologists.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.